Consumer Spec - Pre Market Wrap
RH Pre (+) | WSM Resumed Buy BofA, Bernstein Consumer Initiations (KO, ELF, KDP, MNST, PG, CL, PEP), CCL Pre-Print Setup, PEP Dual PT Cuts, BofA Consumer Charts, Goldman Europe Underperformance
Consumer pre-market trades well in Europe and my feeling is that in the US market wants to rotate away from tech into other areas. Reality is that consumer and macro is healthy — BofA Institute yesterday flagged consumer health "remains strong" with elevated savings and solid May after-tax wage growth across lower/middle income.
In terms of research, Bernstein had a broad consumer initiation where KDP Outperform $38 is the only conviction call while KO, CL, ELF, MNST, PG all land Market Perform — basically confirming what buy-side already suspected. WSM upgraded to Buy at BofA, $250 PT, on the "affordable luxury" $150K HHI thesis. RH beat Q1 and raised FY guide, though Q2 EBITDA margin of 11.5-13% trails Street's 16.6% — classic 2H hockey stick. PEP absorbs double PT cuts (funding short!). TGT, SHOO, PENN, CCL all get PT bumps.
MACRO & MARKETS
INTERESTING CHARTS FROM BOFA:
Always interesting to read Bank of America Institute consumer report:
Key summary:
“Consumer financial health remains strong, with no clear signs of households resorting to borrowing to support spending. While the savings rate has fallen, households' level of savings is relatively elevated. And the seasonal upswing in deposit balances from tax refunds has been larger in 2026 than it was in 2025.”
Consumer positive 1: spending is clearly growing and trending higher
Consumer positive 2: solid growth in May on after tax wage growth in lower/middle income households
MACRO: GOLDMAN FLAGS THREE DRIVERS OF EUROPE UNDERPERFORMANCE
Goldman attributes Europe’s 7% underperformance versus global markets since the conflict began to three factors: energy uncertainty, rising rates, and limited AI exposure. On energy, European economies skew more sensitive to natural gas than oil, with gas prices higher on peak EM summer demand and DM inventory rebuilding, while Brent has fallen below $90/bbl on weaker global demand and the commodities team pushed Strait of Hormuz normalization to end-August from end-June. On rates, the ECB hiked 25 bps with more priced in, and the firm’s economists see Euro area Q4 GDP at 0.2% Y/Y (vs. 1.4% pre-war) and headline inflation at 3.4% Y/Y (vs. 1.5%). On AI, U.S. equities are +8% YTD but only +2% ex-AI while Asia ex-Japan is +18% YTD but down 5% ex-Korea/Taiwan, leaving Europe’s thin tech weighting unable to capture the upside; reports indicate the U.S. and Iran are moving closer to reopening the Strait of Hormuz, and Goldman expects Brent to converge toward $90 in Q4 while remaining more dovish than market on tightening.
CONSUMER STREET RESEARCH
Upgrades
Williams-Sonoma (WSM) Raised to Buy at BofA; PT $250
Downgrades
No consumer sector downgrades today
Initiations
Celsius Holdings (CELH) Rated New Outperform at Bernstein; PT $44
Coca-Cola (KO) Rated New Market Perform at Bernstein
Colgate-Palmolive (CL) Rated New Market Perform at Bernstein
Elf Beauty (ELF) Rated New Market Perform at Bernstein
Estee Lauder (EL) Rated New Market Perform at Bernstein
Keurig Dr Pepper (KDP) Rated New Outperform at Bernstein
Monster Beverage (MNST) Rated New Market Perform at Bernstein
P&G (PG) Rated New Market Perform at Bernstein
PepsiCo (PEP) Rated New Market Perform at Bernstein
EARNINGS REPORTS
RH +0.5%: Q1 BEATS WITH FY26 OUTLOOK RAISED DESPITE TARIFF DRAG
RH posted an adjusted Q1 loss of $1.97 vs. consensus loss of $2.09, with revenue down 1.7% YoY to $800.3M topping the $792.6M consensus.
The company says revenue was reduced by roughly $45M as backorder/special-order balances ran ~$75M higher YoY on tariff-related resourcing, with elevated balances expected to persist through Q2 before normalizing by year-end and potentially contributing ~$75M of 2H26 revenue.
Guidance is mixed. Full-year guide is tweaked higher (they now see sales up 4.5-8% vs. the prior 4-8% w/EBITDA margins of 14.2-16% vs. the prior 14-16%), although the Q2 outlook falls short (they see EBITDA margins of 11.5-13% vs. the Street 16.6%).
CEO Friedman expects 2H acceleration driven by backlog normalization, new stores, and the RH Estates rollout.
Stifel maintains Hold on RH following Q1 earnings but raise PT to $130 on higher prevailing multiples. The firm says results outperformed expectations and eclipsed the high end of Q1 guidance, with RH increasing the low end of FY26 revenue/EBITDA guide. The analyst notes commentary points to weaker Q2 trends meaningfully trailing both Stifel and consensus, giving way to a 2H26 revenue acceleration with underlying incremental EBITDA margins near 50%. The firm adds that reiterated cash flow guidance likely requires inventory investment to support RH Estates, where the launch needs to deliver 5 ppt of 2H revenue, with cannibalization risk from higher trade-program discounts that are “table stakes for winning this business.”
ANALYST RESEARCH & NEWS
WSM: BANK OF AMERICA RESUMES AT BUY, $250 PT
BofA reinstates coverage of WSM at Buy with a $250 PT, expecting the company to remain a “structural share gainer” given a demographic sweet spot where luxury demand is soft and lower-income consumers stay pressured. The firm argues WSM’s “affordable luxury” positioning targets a core customer with roughly $150K household income, supporting relative resilience, with BAC aggregated credit and debit card data showing the spread between higher and lower income furniture spending widening in recent quarters.
BROAD CONSUMER INITIATIONS FROM BERNSTEIN:
ELF: BERNSTEIN SOCGEN INITIATES AT MARKET-PERFORM, PT $60
Bernstein SocGen Group starts e.l.f Beauty at Market-Perform with a $60 PT, calling out the “most relevant operating model for today’s consumer” via social media fluency, rapid innovation, and viral-prone NPD, while flagging that EPS has been highly volatile post the Rhode deal, distribution expansion, elevated marketing/payroll, and a slowing core. The firm is a long-term believer but wants to see stability and margin expansion before the stock works, modeling 2% and 7% NTM/NTM+1 EPS growth, putting it ~5% below consensus on NTM+1.
KO: BERNSTEIN SOCGEN INITIATES AT MARKET-PERFORM, PT $84
Bernstein SocGen Group begins Coca-Cola at Market-Perform with an $84 PT, framing KO as a high-quality compounder with an honorable mention in Functional Beverages (Protein, Hydration) and arguing the global CSD base is set to accelerate alongside the winning zero-calorie cola brand. The firm is bullish on North America but ~1% below consensus on NTM+1 EPS, driven by a bearish LatAm view tied to the 2026 Mexico excise tax weighing on consumption and price realization.
CL: BERNSTEIN SOCGEN INITIATES AT MARKET-PERFORM, PT $96
Bernstein SocGen Group starts Colgate-Palmolive at Market-Perform with a $96 PT, citing the most productive geographic footprint in coverage and strong HPC brands internationally, partially offset by a stagnant, share-losing North America segment. The firm likes the Global Pet business and expects further premiumization as higher-PPP Cat Food outgrows Dog Food.
KDP: BERNSTEIN SOCGEN INITIATES AT OUTPERFORM, PT $38
Bernstein SocGen Group launches Keurig Dr Pepper at Outperform with a $38 PT, highlighting an “outstanding Functional Beverages portfolio” of hot Energy and Hydration brands and arguing the integration risks are well understood and priced in. The firm points to constructive stock reaction to fundamentals, including Q1 2026, and expects Beverages to keep driving appreciation.
MNST: BERNSTEIN SOCGEN INITIATES AT MARKET-PERFORM, PT $95
Bernstein SocGen Group initiates Monster Beverage at Market-Perform with a $95 PT, calling out the best international energy drink business powered by Coca-Cola’s distribution network and the view that US category drivers are global and Energy will keep growing rapidly abroad. The firm sees a solid US brand portfolio sustaining share and sits ~3% above consensus on NTM+1 EPS on higher sales growth and margin, modeling 12%/14% NTM/NTM+1 EPS growth.
PG: BERNSTEIN SOCGEN INITIATES AT MARKET-PERFORM, PT $156
Bernstein SocGen Group starts Procter & Gamble at Market-Perform with a $156 PT, describing the portfolio as diversified by design and therefore hard to accelerate or disrupt. The firm sees Beauty bright spots sustaining LSD organic sales growth with potential upside from Laundry Detergent innovation, but flags persistent private-label pressure in commoditized categories like bath tissue and smaller-competitor pressure in disposable diapers.
PENN: STIFEL RAISES PT TO $25 AFTER MANAGEMENT MEETINGS, MAINTAINS BUY
Stifel takes the PT to $25 from $23 following meetings with CEO and CFO, coming away positive on the 2H26 setup. The firm cites healthy Q2TD retail trends, largely annualized competitive supply headwinds with growth reverting in some impacted markets, an impressive Joliet ramp supporting growth project ROI conviction, an on-plan iCasino-led Interactive strategy with further cost efficiency runway, and recent M&A activity that establishes a valuation floor. Shares are up 44% YTD on the broader sector re-rate, but the analyst still sees relative re-rate potential as Retail EBITDAR inflects, Interactive profitability proves out, net leverage drifts toward <5x, and focus shifts to more material FY27 FCF. Model refinements reflect below-the-line items and Council Bluffs timing.
CCL: STIFEL RAISES PT TO $36 AHEAD OF JUNE 23 PRINT, MAINTAINS BUY
Stifel pushes the PT to $36 from $35 and pushes back on consensus positioning, which the analyst believes is braced for a full-year yield guidance cut on the June 23 print. The firm instead expects CCL to beat F2Q26 yield guidance and slightly raise the full-year, a setup that should drive shares higher by easing concerns around 2H26/1H27 cruise demand. Booking patterns and onboard spending remain healthy, and while Europe-to-Europe demand has softened modestly, the analyst believes it was already embedded in 2026 yield guidance. Stifel reiterates that the 2029 long-term financial targets are “massively underappreciated” and is a buyer into the print.
SHOO: NEEDHAM RAISES PT TO $52 AFTER INVESTOR MEETINGS, MAINTAINS BUY
Needham takes the PT to $52 from $45 following a day of investor meetings with CEO Ed Rosenfeld and IR head Danielle McCoy, reiterating a bullish stance. The firm cites favorable fashion trends, a compelling Kurt Geiger acquisition, and a margin/EPS recovery story driving increasing confidence in business trends. FY26 EPS estimate ticks up $0.02 to $2.10, the high end of guidance, with FY27 moving to $2.60 from $2.52.
TGT: GUGGENHEIM RAISES PT TO $145 AFTER MANAGEMENT MEETING, MAINTAINS BUY
Guggenheim lifts the PT to $145 from $140 after meeting with CEO Michael Fiddelke and CFO Jim Lee, with the discussion centered on improving execution of a “specialization at scale” go-to-market strategy targeting a sizable top-line TAM. The analyst highlights a heavy change agenda this year and next, including returning store conditions to pre-COVID levels, accelerating remodels, and addressing Home, with consistent growth prioritized via differentiated product and experiences aimed at the “busy family” cohort. The 35% YTD rally versus the S&P’s 8% gain suggests the easy money has been made, but persistent progress could attract duration investors and benefit valuation further. The new PT equates to 8.8x 2027E EBITDA.
KMX: BARCLAYS RAISES PT TO $31, MAINTAINS UNDERWEIGHT
Barclays lifts the PT to $31 from $26 but stays Underweight, citing an uneven track record and the potential for meaningful changes in F2027 under the new CEO. The analyst is optimistic on the potential for KMX to materially improve the business but wants more evidence that execution and strategy will deliver growth before turning constructive.
PEP: TD COWEN CUTS PT TO $150, MAINTAINS HOLD
TD Cowen analyst Robert Moskow lowers the PT to $150 from $165 while maintaining a Hold rating, with no further commentary provided.
PEP: PIPER SANDLER AND TD COWEN BOTH CUT PRICE TARGETS, OVERWEIGHT AND HOLD MAINTAINED
Two same-day PT cuts on PEP underscore continued broker debate. Piper Sandler’s Michael Lavery trimmed the PT to $178 from $181 while maintaining Overweight, the more constructive of the two views and effectively a modest mark-to-market refresh. TD Cowen’s Robert Moskow cut more aggressively, lowering the PT to $150 from $165 while maintaining Hold, signaling a more cautious read on the multiple and the multi-year top-line and margin recovery path. Bull case (Piper): the retained Overweight implies the firm still sees relative value, with the PT cut reflecting refreshed numbers rather than a thesis change. Bear case (TD Cowen): the $15 PT cut alongside Hold points to ongoing skepticism on Frito and beverages growth normalization, North American share dynamics, and the timeline to volume recovery.
KMX: BARCLAYS RAISES PT TO 31 FROM 26 BUT MAINTAINS UNDERWEIGHT
Barclays nudges KMX PT to $31 from $26 while maintaining Underweight. The firm says KMX has an uneven track record of performance and there could be meaningful changes in F2027 with the new CEO. The analyst is optimistic on the potential for KMX to meaningfully improve the business but wants to see more signs that execution and strategy will deliver growth before getting more constructive.
Thanks for reading! If you enjoyed Consumer Spec, we’d appreciate you sharing it.
EARNINGS CALENDAR
